Back
VYNE Therapeutics, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Buy
56
VYNE
VYNE Therapeutics, Inc.
Last Price:
$0.57
Seasonality Move:
-5.82%
Sell
38
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$53.22
Seasonality Move:
-13.28%
Buy
56
VYNE Therapeutics, Inc. (VYNE)
is a Buy
Is VYNE Therapeutics, Inc. a Buy, Sell or Hold?
-
The current VYNE Therapeutics, Inc. [VYNE] share price is $0.56. The Score for VYNE is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
VYNE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.34. The Score for CRNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VYNE Stock Price Chart
What is VYNE Therapeutics, Inc.'s stock price today?
-
The VYNE Therapeutics, Inc. share price today is $0.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VYNE is experiencing slight buying pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $53.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VYNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 62.86 | Buy |
| Chaikin Money Flow: | -57573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.38 - 0.58) | Buy |
| Bollinger Bands (100): | (0.3 - 0.46) | Buy |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.96 | Buy |
| Relative Strength Index (14 RSI): | 66.03 | Buy |
| Chaikin Money Flow: | 3428689 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.13 - 49.63) | Buy |
| Bollinger Bands (100): | (35.09 - 47.19) | Buy |
VYNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.57 | Sell |
| 20-day SMA: | 0.51 | Buy |
| 50-day SMA: | 0.42 | Buy |
| 200-day SMA: | 0.81 | Sell |
| 8-day EMA: | 0.54 | Buy |
| 20-day EMA: | 0.42 | Buy |
| 50-day EMA: | 0.23 | Buy |
| 200-day EMA: | 0.07 | Buy |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.2 | Buy |
| 20-day SMA: | 48.28 | Buy |
| 50-day SMA: | 45.42 | Buy |
| 200-day SMA: | 36 | Buy |
| 8-day EMA: | 48.68 | Buy |
| 20-day EMA: | 47.84 | Buy |
| 50-day EMA: | 45.56 | Buy |
| 200-day EMA: | 40.15 | Buy |
VYNE Therapeutics, Inc. Earnings Growth & VYNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.21 per share, and a decrease next year of $0.55 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.
VYNE Therapeutics, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||